Nucleophosmin (NPM1) is a protein of highly conserved nature which works as a molecular chaperone and ismostly found in nucleoli. NPM also involved in the maturation of preribosomes and duplication of centrosomes.Furthermore, it is also active in control and regulation of the ARF-p53 tumor suppressor pathway. A high rateof incidence and prognostic involvement is reported by various authors in AML patients. In AML it behaves as afavorable prognostic marker. NPM mutations are more frequently associated with normal-karyotype AML andare usually absent in patients having abnormal or poor cytogenetic. NPM mutations are not frequent in otherhematopoietic tumors .Two main types of mutations have been described to date. Both of these cause abnormalcytoplasmic localization of NPM1. Their high incidence rate in normal karyoptype and their favorable naturem ake those mutations hot spot or front face mutations which should be checked before treatment starts.
(2013). Prognostic Involvement of Nucleophosmin Mutations in Acute Myeloid Leaukemia. Asian Pacific Journal of Cancer Prevention, 14(10), 5615-5620.
MLA
. "Prognostic Involvement of Nucleophosmin Mutations in Acute Myeloid Leaukemia". Asian Pacific Journal of Cancer Prevention, 14, 10, 2013, 5615-5620.
HARVARD
(2013). 'Prognostic Involvement of Nucleophosmin Mutations in Acute Myeloid Leaukemia', Asian Pacific Journal of Cancer Prevention, 14(10), pp. 5615-5620.
VANCOUVER
Prognostic Involvement of Nucleophosmin Mutations in Acute Myeloid Leaukemia. Asian Pacific Journal of Cancer Prevention, 2013; 14(10): 5615-5620.
)